Assignee
ICN PHARMACEUTICALS
45 granted patents·2,459 citations·filing 1972–2002
Top patents by PatentIndex Score
45 records- 0198US6573248B2Monocyclic L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2001·Granted Jun 3, 2003·179 cites·10 claims
- 0298US4093624A1,2,4-Thiadiazolidine-3,5-dioneICN PHARMACEUTICALS·Filed 1977·Granted Jun 6, 1978·84 cites·1 claims
- 0397US6479463B1Purine L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2000·Granted Nov 12, 2002·123 cites·5 claims
- 0496US6642206B2Monocyclic L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2002·Granted Nov 4, 2003·102 cites·5 claims
- 0596US6130326AMonocyclic L-Nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 1999·Granted Oct 10, 2000·139 cites·4 claims
- 0695US6552183B1Moncyclic L-nucleosides analogsICN PHARMACEUTICALS·Filed 2000·Granted Apr 22, 2003·74 cites·2 claims
- 0795US6509320B1Purine L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2000·Granted Jan 21, 2003·83 cites·3 claims
- 0895US5767097ASpecific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytesICN PHARMACEUTICALS·Filed 1996·Granted Jun 16, 1998·212 cites·9 claims
- 0994US6403566B1Nucleosides having bicyclic sugar moietyICN PHARMACEUTICALS·Filed 1999·Granted Jun 11, 2002·165 cites·8 claims
- 1094US5681940ASugar modified nucleosides and oligonucleotidesICN PHARMACEUTICALS·Filed 1994·Granted Oct 28, 1997·140 cites·9 claims
- 1194US4036840A2-Substituted-s-triazolo[1,5a]pyrimidinesICN PHARMACEUTICALS·Filed 1975·Granted Jul 19, 1977·45 cites·12 claims
- 1293US6063772ASpecific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytesICN PHARMACEUTICALS·Filed 1998·Granted May 16, 2000·111 cites·9 claims
- 1392US4093617A3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidinesICN PHARMACEUTICALS·Filed 1976·Granted Jun 6, 1978·27 cites·8 claims
- 1491US4093714A9β-D-Arabinofuranosylpurine nucleotides and method of useICN PHARMACEUTICALS·Filed 1974·Granted Jun 6, 1978·52 cites·14 claims
- 1589US5712378ASugar modified nucleosides and their use for synthesis of oligonucleotidesICN PHARMACEUTICALS·Filed 1995·Granted Jan 27, 1998·71 cites·6 claims
- 1689US3984396A1-(β,-D-ribofuranosyl)-1,2,4-triazole acid estersICN PHARMACEUTICALS·Filed 1974·Granted Oct 5, 1976·29 cites·14 claims
- 1787US6017898AInhibition of tumor growth by antisense oligonucleotides for IL-8 and IL-8 receptorICN PHARMACEUTICALS·Filed 1998·Granted Jan 25, 2000·83 cites·2 claims
- 1886US6191266B1Sugar modified nucleosidesICN PHARMACEUTICALS·Filed 1996·Granted Feb 20, 2001·60 cites·3 claims
- 1986US6083482AConformationally locked nucleosides and oligonucleotidesICN PHARMACEUTICALS·Filed 1999·Granted Jul 4, 2000·92 cites·7 claims
- 2086US5849903AAntisense oligonucleotides for IL-8 and IL-8 receptorICN PHARMACEUTICALS·Filed 1997·Granted Dec 15, 1998·71 cites·7 claims
- 2186US4432975AProcess for introducing vitamin B-12 into the bloodstreamICN PHARMACEUTICALS·Filed 1981·Granted Feb 21, 1984·92 cites·13 claims
- 2285US6150337ASpecific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytesICN PHARMACEUTICALS·Filed 1998·Granted Nov 21, 2000·83 cites·6 claims
- 2385USD408957SPortion of a transport and storage vessel for radioactive materialsICN PHARMACEUTICALS·Filed 1996·Granted Apr 27, 1999·30 cites·1 claims
- 2484US4138547AProcess for preparing 1,2,4-triazole nucleosidesICN PHARMACEUTICALS·Filed 1977·Granted Feb 6, 1979·24 cites·4 claims
- 2582US3976545A1,2,4-Triazol E-3-carboxamides as antiviral agentsICN PHARMACEUTICALS·Filed 1975·Granted Aug 24, 1976·17 cites·5 claims
- 2680US5723589ACarbohydrate conjugated bio-active compoundsICN PHARMACEUTICALS·Filed 1995·Granted Mar 3, 1998·50 cites·15 claims
- 2779US5969135AOligonucleotide analogs with an amino acid or a modified amino alcohol residueICN PHARMACEUTICALS·Filed 1995·Granted Oct 19, 1999·28 cites·9 claims
- 2879US4021556AXanthine oxidase inhibitorsICN PHARMACEUTICALS·Filed 1975·Granted May 3, 1977·34 cites·6 claims
- 2976US4058659A6,8-Disubstituted purine derivatives of 9-β-D-ribofuranosyl 3',5'-cyclic phosphateICN PHARMACEUTICALS·Filed 1975·Granted Nov 15, 1977·15 cites·17 claims
- 3075US3948886A6-Substituted purine 3',5'-cyclic nucleotidesICN PHARMACEUTICALS·Filed 1973·Granted Apr 6, 1976·14 cites·7 claims
- 3171US3948885A5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleosideICN PHARMACEUTICALS·Filed 1973·Granted Apr 6, 1976·14 cites·2 claims
- 3269US4246408AImidazo[1,2-a]-s-triazineICN PHARMACEUTICALS·Filed 1979·Granted Jan 20, 1981·5 cites·1 claims
- 3369US4038480A6-aminocarbonyl purine 3',5'-cyclic nucleotidesICN PHARMACEUTICALS·Filed 1973·Granted Jul 26, 1977·12 cites·22 claims
- 3469US3991078AN-substituted 1,2,4-triazolesICN PHARMACEUTICALS·Filed 1974·Granted Nov 9, 1976·11 cites·1 claims
- 3568US5990299AControl of CD44 gene expression for therapeutic useICN PHARMACEUTICALS·Filed 1995·Granted Nov 23, 1999·29 cites·4 claims
- 3668US4056674ADerivatives of 3-deazaguanineICN PHARMACEUTICALS·Filed 1975·Granted Nov 1, 1977·8 cites·14 claims
- 3761US3968101A8-Substituted cyclic nucleotides by free radical alkylation and acylationICN PHARMACEUTICALS·Filed 1974·Granted Jul 6, 1976·9 cites·17 claims
- 3854US5907036AProcedures for obtaining ribo-C-nucleosidesICN PHARMACEUTICALS·Filed 1996·Granted May 25, 1999·7 cites·11 claims
- 3953US6613896B1Method of producing tiazofurin and other C-nucleosidesICN PHARMACEUTICALS·Filed 1998·Granted Sep 2, 2003·9 cites·21 claims
- 4051US3968103A1,2,3-Triazole nucleosidesICN PHARMACEUTICALS·Filed 1972·Granted Jul 6, 1976·5 cites·13 claims
- 4143US4328336A9-(β-D-Ribofurandsyl)purine-6-carboxamide and related compoundsICN PHARMACEUTICALS·Filed 1980·Granted May 4, 1982·4 cites·7 claims
- 4242US6211201B1Multivalent salts of pyridostigmine and related compoundsICN PHARMACEUTICALS·Filed 1997·Granted Apr 3, 2001·6 cites·20 claims
- 4340US5783832APackaging with centrifuge tubeICN PHARMACEUTICALS·Filed 1997·Granted Jul 21, 1998·7 cites·17 claims
- 4435US5763419ATreatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic monophasphateICN PHARMACEUTICALS·Filed 1995·Granted Jun 9, 1998·2 cites·12 claims
- 4532US5798250AFacilitating hepatitus virus infection in cell culture using a membrane stressorICN PHARMACEUTICALS·Filed 1996·Granted Aug 25, 1998·2 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when ICN PHARMACEUTICALS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →